Miranda Schmalfuhs

home / authors / miranda-schmalfuhs

Miranda Schmalfuhs is the associate group social media editor of Pharmaceutical Executive, Pharmaceutical Commerce, and Applied Clinical Trials and can be reached at mschmalfuhs@mjhlifesciences.com.

Articles

Pharma Pulse 12/3/24: Shaping the Future of Commercialization, Looming PREP Act Expiration Could Impact Rural Patients & more

Pharma Pulse 12/3/24: Shaping the Future of Commercialization, Looming PREP Act Expiration Could Impact Rural Patients & more

Miranda Schmalfuhs
December 3rd 2024

The latest news for pharma industry insiders.

Pharma Pulse 12/2/24: Retooling the ‘Gene’ Value Machine & more

Pharma Pulse 12/2/24: Retooling the ‘Gene’ Value Machine & more

Miranda Schmalfuhs
December 2nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/29/24: AI’s Role in Personalizing Life Sciences Digital Experiences & more

Pharma Pulse 11/29/24: AI’s Role in Personalizing Life Sciences Digital Experiences & more

Miranda Schmalfuhs
November 29th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more

Pharma Pulse 11/28/24: Nov. 27 Passed—What Does That Mean for DSCSA? & more

Miranda Schmalfuhs
November 28th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/27/24: Empowering Sites and Patients, Shingles Can Occur in Children & more

Pharma Pulse 11/27/24: Empowering Sites and Patients, Shingles Can Occur in Children & more

Miranda Schmalfuhs
November 27th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more

Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more

Miranda Schmalfuhs
November 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Miranda Schmalfuhs
November 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse

Pharma Pulse 11/22/24: Challenges Facing the Pharma Industry in 2025 & more

Miranda Schmalfuhs
November 22nd 2024

The latest news for pharma industry insiders.

Pulse

Pharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & more

Miranda Schmalfuhs
November 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse

Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More

Miranda Schmalfuhs
November 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse

Pharma Pulse 11/19/24: Is Any Data Better Than No Data? Exploring Emerging Vitiligo Therapies & more

Miranda Schmalfuhs
November 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/18/24: An Overview of RFID, Moving More Modifies Mood & more

Pharma Pulse 11/18/24: An Overview of RFID, Moving More Modifies Mood & more

Miranda Schmalfuhs
November 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/15/24: SARS-CoV-2 Infection Impact Child Neurodevelopment, History of ED Increases Risk of Psychiatric Disorders for Children & more

Pharma Pulse 11/15/24: SARS-CoV-2 Infection Impact Child Neurodevelopment, History of ED Increases Risk of Psychiatric Disorders for Children & more

Miranda Schmalfuhs
November 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/14/24: Global Disparities in Cancer Burden, What Happens if Millions Lose Access to GLP-1s & more

Pharma Pulse 11/14/24: Global Disparities in Cancer Burden, What Happens if Millions Lose Access to GLP-1s & more

Miranda Schmalfuhs
November 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/13/24: FDA's Exemption for DSCSA Compliance, Pharmacists Combat Flu Misinformation and Expand Vaccine Access & more

Pharma Pulse 11/13/24: FDA's Exemption for DSCSA Compliance, Pharmacists Combat Flu Misinformation and Expand Vaccine Access & more

Miranda Schmalfuhs
November 13th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

Miranda Schmalfuhs
November 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/11/24: The Importance of Improving DE&I in Clinical Trials, Financial Toxicity About More Than Just Affording Treatment & more

Pharma Pulse 11/11/24: The Importance of Improving DE&I in Clinical Trials, Financial Toxicity About More Than Just Affording Treatment & more

Miranda Schmalfuhs
November 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more

Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more

Miranda Schmalfuhs
November 8th 2024

The latest news for pharma industry insiders.

Advertising/Marketing Trends to Expect in Q1 of 2025

Advertising/Marketing Trends to Expect in Q1 of 2025

Miranda Schmalfuhs
November 8th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab, identifies advertising/marketing trends he expects in Q1 of 2025.

Healthcare Serving as a Roadmap for Other Sectors

Healthcare Serving as a Roadmap for Other Sectors

Miranda Schmalfuhs
November 7th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explains how the healthcare industry's experience with privacy-compliant targeting can serve as a roadmap for other sectors.

Pharma Pulse 11/7/24: Women Within Health Care Face Financial Disparities, The New Frontier for Clinical Research Excellence & more

Pharma Pulse 11/7/24: Women Within Health Care Face Financial Disparities, The New Frontier for Clinical Research Excellence & more

Miranda Schmalfuhs
November 7th 2024

The latest news for pharma industry insiders.

Potential Implications of Phasing-Out Cookies

Potential Implications of Phasing-Out Cookies

Miranda Schmalfuhs
November 6th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explored the potential implications of the phase-out of cookies for the broader advertising industry.

Experts Weigh-In on Compounded GLP-1/Semaglutide Solution

Experts Weigh-In on Compounded GLP-1/Semaglutide Solution

Miranda Schmalfuhs
November 6th 2024

Industry experts comment on the increasing popularity of compounded medications, particularly GLP-1s, due to drug shortages and the desire for personalized treatments.

Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

Miranda Schmalfuhs
November 6th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/5/24: FDA’s Diversity Action Plan Guidance, Combatting Medical Misinformation & more

Pharma Pulse 11/5/24: FDA’s Diversity Action Plan Guidance, Combatting Medical Misinformation & more

Miranda Schmalfuhs
November 5th 2024

The latest news for pharma industry insiders.

Balancing Personalized Targeting with Protecting Consumer Privacy

Balancing Personalized Targeting with Protecting Consumer Privacy

Miranda Schmalfuhs
November 5th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discusses the need to balance personalized targeting with the ethical imperative to protect consumer privacy.

Promising Alternative Targeting Methods in a Post-Cookie World

Promising Alternative Targeting Methods in a Post-Cookie World

Miranda Schmalfuhs
November 4th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explores the most promising alternative targeting methods that advertisers can adopt in a post-cookie world, and how they compare to traditional approaches.

Pharma Pulse 11/4/24: Community Pharmacies in Crisis, Insights Into ADHD Diagnoses in Adult Women & more

Pharma Pulse 11/4/24: Community Pharmacies in Crisis, Insights Into ADHD Diagnoses in Adult Women & more

Miranda Schmalfuhs
November 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/1/24: Navigating Diversity and Digital Innovation, Key Clinical Information on Infertility & more

Pharma Pulse 11/1/24: Navigating Diversity and Digital Innovation, Key Clinical Information on Infertility & more

Miranda Schmalfuhs
November 1st 2024

The latest news for pharma industry insiders.

Key Benefits of RWD in Privacy and Targeting Effectiveness

Key Benefits of RWD in Privacy and Targeting Effectiveness

Miranda Schmalfuhs
November 1st 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discussed how the use of Real-World Data has evolved in the healthcare industry in terms of privacy and targeting effectiveness.

<12345678910
...
18>

Latest Updated Articles

Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Published: June 19th 2024 | Updated: June 24th 2024
Utilizing Biomarkers to Develop First-in-Class Antibody Drug Conjugates to Treat Advanced Solid Tumors
Jennifer Butler
Published: March 11th 2025 | Updated: March 21st 2025
The Misinformation Maze: Navigating Public Health in the Digital Age
Beyond the Data: Making HCP Analytics Actually Work for Commercial Teams
Published: February 21st 2025 | Updated: March 21st 2025
Beyond the Data: Making HCP Analytics Actually Work for Commercial Teams
Bimzelx Demonstrates Sustained Skin Clearance in Moderate-to-Severe Plaque Psoriasis
Published: March 7th 2025 | Updated: March 21st 2025
Bimzelx Demonstrates Sustained Skin Clearance in Moderate-to-Severe Plaque Psoriasis
DB-OTO and the Evolving Approach to Genetic Deafness in Children
Published: March 7th 2025 | Updated: March 21st 2025
DB-OTO and the Evolving Approach to Genetic Deafness in Children
Kristine Ashcraft
Published: February 28th 2025 | Updated: March 21st 2025
Screening for DPYD: Q&A with Kristine Ashcraft